Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities.
What Alembic files
- Others153
- Updates64
- Investor Meet40
- Important39
- Dividend/Bonus19
- Board Meeting15
Alembic Pharma announced record dates for the maturity of its Commercial Papers (CPs) totaling ₹750 Cr. If you hold these CPs, record dates fall between September 10-25, 2026, for maturities from September 11-28, 2026. This determines eligibility for your maturity payment.
Alembic Pharmaceuticals has set July 29, 2026, as the Record Date for its equity dividend payout for the financial year ended March 31, 2026. Shareholders holding shares on this date will be eligible for the dividend. Payment is expected on or from August 6, 2026, subject to approval at the...
Alembic Pharma announced record dates for the maturity of its Commercial Papers (debt instruments). For investors holding ISIN INE901L14CJ8 (Rs 100 Cr), the record date is June 8, 2026, for maturity on June 9. For ISIN INE901L14CI0 (Rs 150 Cr), the record date is June 14, 2026, for maturity on...
Alembic Pharmaceuticals' Board has announced a dividend of Rs. 12 per equity share for FY2025-26, translating to a 600% payout. This marks a positive increase from the Rs. 11 per share (550% payout) distributed for the previous financial year. This decision reflects a commitment to enhancing shareholder returns, signaling confidence...
Alembic Pharma sets record dates for its Commercial Papers. For the Rs 150 Cr CP (ISIN INE901L14CG4), May 6, 2026, is the record date for May 7, 2026, maturity. For the other Rs 150 Cr CP (ISIN INE901L14CH2), May 28, 2026, is the record date for May 29, 2026, maturity....